medigraphic.com
SPANISH

Médica Sur

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 2

Next >>

Med Sur 2014; 21 (2)

Presentación aguda de hepatitis autoinmune

Manzano-Robleda MC, Fernández-Rivero JA, Ornelas-Arroyo S, Toapanta-Yanchapaxi LN, Chávez-Tapia NC, Méndez-Sánchez N, Uribe-Esquivel M
Full text How to cite this article

Language: Spanish
References: 10
Page: 52-54
PDF size: 119.88 Kb.


Key words:

Acute autoimmune hepatitis, ALT, Bilirubin.

ABSTRACT

Introduction. Presentation of autoimmune hepatitis may be variable from a chronic liver disease to an acute or fulminant hepatitis. Acute onset of autoimmune hepatitis can mimic an acute viral, toxic hepatitis or an acute presentation. Aim. Determine the clinical curse of patients with acute presentation of autoimmune hepatitis. Material and methods. We enrolled adult patients with clinical symptoms, elevation of serum ALT ≥ 5 fold UNL; bilirubin level › 2 mg/dL, and simplified IAIHG score ≥ 6 points. In all patients most be ruled out virus infection, drug-induced, hypoxic and alcoholic hepatitis. We describe the clinical and biochemical characteristics, as well as management of these patients. Results. We include four patients, three women and one man with an age range from 51 to 61 years old. Most patients were female, one of them was completely asymptomatic at the moment of diagnosis, the main laboratory alteration was elevated ALT and bilirubin, all patients received double treatment with corticosteroid and azathioprin with clinical and laboratory improvement. Conclusion. Acute presentation of autoimmune hepatitis is an unusual presentation. In these cases the immunosuppressive treatment improve clinical and biochemical outcomes.


REFERENCES

  1. Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002; 36(2): 479-97.

  2. Ferrari R, et al. Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the ‘acute’ type. QJM 2004; 97(7): 407-12.

  3. Czaja AJ. Acute and Acute Severe (Fulminant) Autoimmune Hepatitis. Dig Dis Sci 2012.

  4. Takahashi H, Zeniya M. Acute presentation of autoimmune hepatitis: Does it exist? A published work review. Hepatol Res 2011; 41(6): 498-504.

  5. Lee WM, Stravitz RT, Larson AM. Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. Hepatology 2012; 55(3): 965-7.

  6. Wang YM, Yan ZH. Comment on the AASLD position paper: the management of acute liver failure. Zhonghua Gan Zang Bing Za Zhi 2006; 14(1): 72-5.

  7. Stravitz RT, et al. Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology 2011; 53(2): 517-26.

  8. Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006; 354(1): 54-66.

  9. Manns MP, et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010; 51(6): 2193-213.

  10. Czaja AJ. Special clinical challenges in autoimmune hepatitis: the elderly, males, pregnancy, mild disease, fulminant onset, and nonwhite patients. Semin Liver Dis 2009; 29(3): 315-30.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Sur. 2014;21